Last reviewed 2026-04-20 · How we verify

Injectable coenzyme I

Anhui Provincial Hospital · FDA-approved active Small molecule Quality 5/100

At a glance

Generic name	Injectable coenzyme I
Sponsor	Anhui Provincial Hospital
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A IB/II Phase Clinical Study on the Safety, Tolerability, and Efficacy of SHR-9839(sc) in Combination Anti-tumor Therapy in Patients With Solid Tumors (PHASE1, PHASE2)
Venetoclax Basket Trial for High Risk Hematologic Malignancies (PHASE1)
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults (PHASE3)
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults (PHASE3)
VCOM Pain Free Research Collaborative (NA)
Botulinum Toxin Injection in Reducing Scar Following Cheilorrhaphy. (NA)
Botulinum Toxin Versus Platelet Rich Fibrin for TMJ Internal Derangement (NA)
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results